HAE

SEC source: 0001127602-24-015868 · form4.xml · nonDerivative · entry 3

Llorens Josep · CIK 0001750812 · EVP, Global Manufacturing

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,172

F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated August 28, 2023 (fully executed as of August 31, 2023).

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-015868 · form4.xml · nonDerivative · entry 2

Llorens Josep · CIK 0001750812 · EVP, Global Manufacturing

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,942

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-015854 · form4.xml · nonDerivative · entry 2

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,448

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported as well as 289 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.

SEC source: 0001127602-24-015864 · form4.xml · nonDerivative · entry 2

DArecca James · CIK 0001583903 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,907

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-015834 · form4.xml · nonDerivative · entry 2

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,640

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-015888 · form4.xml · nonDerivative · entry 1

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,860

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-24-015882 · form4.xml · nonDerivative · entry 1

Galvin Roy · CIK 0001950021 · President, Global Plasma & BC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,538

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported as well as 157 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.

SEC source: 0001127602-24-015876 · form4.xml · nonDerivative · entry 1

Maunsell Farris Maryanne · CIK 0001950052 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 557

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-015872 · form4.xml · nonDerivative · entry 1

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,856

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-015870 · form4.xml · nonDerivative · entry 1

Miller Laurie A. · CIK 0001881751 · SVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,393

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported, 134 shares acquired by the reporting person on October 31, 2023 under the Issuer's 2007 Employee Stock Purchase Plan (as amended, the "ESPP") and 129 shares acquired by the reporting person on April 30, 2024 under the ESPP.

SEC source: 0001127602-24-015868 · form4.xml · nonDerivative · entry 1

Llorens Josep · CIK 0001750812 · EVP, Global Manufacturing

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,205

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-015854 · form4.xml · nonDerivative · entry 1

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,355

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported as well as 289 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.

SEC source: 0001127602-24-015864 · form4.xml · nonDerivative · entry 1

DArecca James · CIK 0001583903 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,258

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-015834 · form4.xml · nonDerivative · entry 1

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,958

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-014594 · form4.xml · nonDerivative · entry 1

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,295

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).

F2 · balance_after: This number includes unvested restricted stock units previously reported as well as 289 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.

SEC source: 0001127602-24-014274 · form4.xml · nonDerivative · entry 1

DArecca James · CIK 0001583903 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,670

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-013101 · form4.xml · nonDerivative · entry 1

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,311

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-24-009995 · form4.xml · nonDerivative · entry 1

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,546

F1 · kind: These securities were transferred by the reporting person as a gift without any consideration to the Simon Family 2020 Irrevocable Trust for the benefit of the reporting person's children, which trust has an independent trustee.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-026759 · form4.xml · nonDerivative · entry 1

Galvin Roy · CIK 0001950021 · President, Global Plasma & BC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,595

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported as well as 66 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2023.

SEC source: 0001127602-23-026191 · form4.xml · nonDerivative · entry 1

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,101

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-23-026198 · form4.xml · nonDerivative · entry 1

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,272

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-23-024307 · form4.xml · nonDerivative · entry 1

Miller Laurie A. · CIK 0001881751 · SVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,363

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-23-024070 · form4.xml · nonDerivative · entry 1

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,221

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023).

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-024071 · form4.xml · nonDerivative · entry 1

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,495

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-023851 · form4.xml · nonDerivative · entry 1

Dockendorff Charles J · CIK 0001400563 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,226

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated May 26, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.19 to $88.01, inclusive. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-022209 · form4.xml · nonDerivative · entry 1

Bryant Diane M · CIK 0001687544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,226

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

SEC source: 0001127602-23-022207 · form4.xml · nonDerivative · entry 1

Dockendorff Charles J · CIK 0001400563 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,441

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

SEC source: 0001127602-23-022206 · form4.xml · nonDerivative · entry 1

Zane Ellen M · CIK 0001369850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,473

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

SEC source: 0001127602-23-022205 · form4.xml · nonDerivative · entry 1

Pomeroy Claire · CIK 0001603648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,972

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

SEC source: 0001127602-23-022202 · form4.xml · nonDerivative · entry 1

KROLL MARK W · CIK 0001259254 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,457

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

SEC source: 0001127602-23-022201 · form4.xml · nonDerivative · entry 1

Johnson Lloyd Emerson · CIK 0001708823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,033

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

SEC source: 0001127602-23-022200 · form4.xml · nonDerivative · entry 1

COYLE MICHAEL J · CIK 0001233311 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,494

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

SEC source: 0001127602-23-022197 · form4.xml · nonDerivative · entry 1

ABERNATHY ROBERT E · CIK 0001222888 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,081

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

SEC source: 0001127602-23-021080 · form4.xml · derivative · entry 5

Llorens Josep · CIK 0001750812 · EVP, Global Manufacturing

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,611

Underlying: Common Stock · 2,537 shares

Expires 2029-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated August 22, 2022.

F3 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-23-021080 · form4.xml · derivative · entry 4

Llorens Josep · CIK 0001750812 · EVP, Global Manufacturing

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,782

Underlying: Common Stock · 2,391 shares

Expires 2028-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated August 22, 2022.

F3 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-23-021080 · form4.xml · nonDerivative · entry 3

Llorens Josep · CIK 0001750812 · EVP, Global Manufacturing

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,463

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated August 22, 2022.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-021080 · form4.xml · nonDerivative · entry 2

Llorens Josep · CIK 0001750812 · EVP, Global Manufacturing

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,391

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated August 22, 2022.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-021080 · form4.xml · nonDerivative · entry 1

Llorens Josep · CIK 0001750812 · EVP, Global Manufacturing

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan dated August 22, 2022.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-019619 · form4.xml · derivative · entry 3

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 196,746 shares

Expires 2023-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents an automatic exercise of options granted in 2016 and scheduled to expire after June 29, 2023, as reflected in this Form 4.

F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-23-019619 · form4.xml · nonDerivative · entry 2

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,446

F3 · shares: Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-019619 · form4.xml · nonDerivative · entry 1

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,113

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents an automatic exercise of options granted in 2016 and scheduled to expire after June 29, 2023, as reflected in this Form 4.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-018423 · form4.xml · derivative · entry 6

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,231

Underlying: Common Stock · 2,410 shares

Expires 2029-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-23-018423 · form4.xml · derivative · entry 5

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,483

Underlying: Common Stock · 4,483 shares

Expires 2028-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-23-018423 · form4.xml · nonDerivative · entry 4

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,449

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.96 to $88.12, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this report.

F1 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-23-018423 · form4.xml · nonDerivative · entry 3

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,987

F2 · shares: Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.

F1 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-23-018423 · form4.xml · nonDerivative · entry 2

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,040

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-23-018423 · form4.xml · nonDerivative · entry 1

Strong Stewart W · CIK 0001420910 · President, Global Hospital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-23-017841 · form4.xml · nonDerivative · entry 1

Miller Laurie A. · CIK 0001881751 · SVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,572

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-23-017355 · form4.xml · nonDerivative · entry 1

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,800

F1 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-23-016314 · form4.xml · nonDerivative · entry 1

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,104

F1 · shares: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2 · balance_after: This number includes unvested RSUs previously reported.